6 Best Peptides for Hangover Recovery

What to Know Before Choosing a Peptide for Hangover Recovery

A hangover is not one problem. It is three or four biochemical problems colliding at once: a buildup of acetaldehyde, the toxic intermediate your liver produces when it breaks down alcohol; damage to the gut lining that lets bacterial endotoxins into the bloodstream; a steep drop in the coenzyme NAD+ that leaves your cells running on fumes; and a downstream inflammatory cascade that eventually reaches the brain. The peptides and peptide-related compounds people reach for in this space each address one or more of those mechanisms. Some have been tested in human clinical trials. Others rest on animal data, on use in adjacent clinical settings like alcohol withdrawal, or on consistent community-reported experience. Both kinds belong in this guide.

The inclusion criterion here is straightforward: a compound earns a slot if people use it or are actively discussing it for hangover recovery. FDA approval status, clinical trial depth, and whether a compound is available by prescription or only through research channels are not filters. Evidence strength is stated honestly inside each entry, not used to decide who makes the list.

The entries below are numbered by how prominently each compound appears in the research and in real-world use. That ordering is a spine for the list, not a verdict. Entry one is not necessarily the right choice for you; it is the compound with the deepest footprint in both published literature and the community conversation around this goal. The honest field-wide context: no peptide has been FDA-approved for hangover recovery, and the human trial record across this entire space is thin. Glutathione and ghrelin have published human data for alcohol-related outcomes. Most other compounds here are supported by animal studies, adjacent clinical use, or community-reported experience. That range is real, and each entry is clear about where its compound sits on that spectrum.

1. Glutathione: The Only Compound With a Published Hangover RCT

Glutathione is technically a tripeptide, a three-amino-acid molecule built from glycine, cysteine, and glutamate, which places it squarely in the peptide category even though most people encounter it framed as an antioxidant supplement. It is the most clinically validated compound in this entire field for hangover-specific use, and the margin is not close.

The reason glutathione matters for hangovers comes down to acetaldehyde. When you drink, your liver converts ethanol into acetaldehyde through a first enzymatic step, then converts acetaldehyde into the far more benign acetate through a second. The second step is the bottleneck. When alcohol intake overwhelms the enzyme responsible for that conversion, acetaldehyde accumulates in the blood. It binds to cellular proteins, damages tissue, triggers nausea, and causes headache. Glutathione addresses this directly: when the normal enzymatic clearance pathway is overloaded, glutathione acts as a conjugation partner, binding to acetaldehyde and neutralizing it before it can cause further damage. It also replenishes antioxidant defenses that alcohol metabolism depletes through a secondary pathway that generates reactive oxygen species as a byproduct.

The evidence behind this is genuinely clinical. A randomized controlled trial published in 2024 found that glutathione supplementation significantly reduced serum acetaldehyde at every measured time point compared to placebo, with a statistical result of p less than 0.001. That is a clean finding from a well-designed study, and it makes glutathione the only compound in this list with a published human RCT directly demonstrating a hangover-relevant effect. The trial also found it safe for human use at the studied doses.

In real-world use, injectable glutathione is the format most discussed in biohacking communities, where users consistently report waking up with markedly reduced or absent nausea and headache after drinking. IV glutathione is available at IV therapy clinics and carries a well-established safety profile in those clinical settings. Oral glutathione is widely available as a supplement but has lower bioavailability than injectable or IV forms; many users opt for N-acetyl cysteine, a glutathione precursor, when an injectable format is not accessible. The main safety consideration is that injectable and IV formats are not appropriate for people with certain kidney or heart conditions.

2. BPC-157: For Gut Barrier Repair and Brain Fog

BPC-157, short for Body Protection Compound-157, is a 15-amino-acid synthetic peptide derived from a protective protein found in gastric juice. It does not work through the same acetaldehyde pathway as glutathione. Its target is the gut barrier, which makes it relevant to a different piece of hangover biology: the brain fog and headache that stem from neuroinflammation rather than direct toxicity.

Here is the sequence BPC-157 is thought to interrupt. Alcohol damages the tight junction proteins that hold intestinal cells together, proteins called occludin and claudin-1 that form a physical seal preventing bacteria and their byproducts from passing through the gut wall. When those junctions break down, lipopolysaccharide endotoxins from gut bacteria cross into systemic circulation. The immune system responds by releasing pro-inflammatory cytokines, particularly TNF-alpha and interleukin-6. Those cytokines cross the blood-brain barrier and drive neuroinflammation, which is the most likely source of the cognitive heaviness and headache many people describe as the most debilitating part of a hangover. BPC-157 appears to accelerate repair of those tight junction proteins by upregulating growth hormone receptor signaling, tightening the gut barrier and cutting off the endotoxin leak at its source.

In animal studies, this picture is well-supported. More than 90 animal studies have examined BPC-157 across gut protection, tissue repair, and inflammatory contexts, with data showing intestinal permeability reduction and suppression of TNF-alpha elevation within hours of alcohol exposure. No human clinical trial has been published for BPC-157 in hangover recovery as of 2026.

On the community side, BPC-157 in intranasal form is one of the two most consistently endorsed compounds in biohacking forums alongside glutathione. Users cite it for reducing nausea and clearing cognitive fog after heavy drinking, with some reporting zero hangovers across extended periods of use when taking it before and during drinking occasions rather than only afterward. As of February 2026, BPC-157 was reclassified to allow legal compounding by licensed pharmacies under physician prescription, improving access through telemedicine channels. One important consideration for competitive athletes: BPC-157 is prohibited by the World Anti-Doping Agency, with detectable metabolites for several days after use.

3. NAD+: For Energy and Cognitive Restoration

NAD+, or nicotinamide adenine dinucleotide, is a coenzyme rather than a traditional peptide. It earns a place in this guide because it is the most commonly co-listed compound with peptides in hangover-recovery discussions, and the biological rationale for that is legitimate and grounded in well-understood biochemistry.

Alcohol metabolism consumes NAD+ at a high rate. The enzymatic steps that convert ethanol into acetaldehyde and acetaldehyde into acetate both require NAD+ as a cofactor. After a significant drinking session, NAD+ levels are substantially depleted. That depletion impairs the electron transport chain inside your mitochondria, which is the mechanism your cells use to generate energy. Think of NAD+ as the molecule that keeps the power plant running; without enough of it, cellular energy production stalls. The result is the crushing fatigue, difficulty concentrating, and general inability to function that define the morning-after experience. Restoring NAD+ is thought to reverse that impairment by giving the electron transport chain what it needs to resume normal function and by enabling the liver to complete the ethanol-to-acetate conversion more efficiently.

The clinical evidence for NAD+ in hangover recovery specifically is limited. No large-scale randomized controlled trials dedicated to this use have been published as of 2026. What exists is a strong mechanistic and biochemical case, which is more than pure speculation but is not the same as a clinical trial. NAD+ IV therapy is used in clinical settings for alcohol withdrawal, representing adjacent clinical application in an alcohol-related context. Community reports consistently describe NAD+ as the compound that restores energy, mood, and cognitive clarity the morning after drinking, with most accounts focusing on the mental dimension of recovery rather than physical symptoms like nausea. Oral NAD+ precursors such as nicotinamide riboside and nicotinamide mononucleotide are widely available as supplements and are considered more bioavailable orally than direct NAD+ supplementation. IV NAD+ is available at specialized clinics and is generally well-tolerated, though administering it too rapidly can cause transient flushing or discomfort.

4. Ghrelin: The One Peptide With a Human Hangover Trial

Ghrelin occupies a genuinely unusual position in this field. It is a naturally occurring peptide hormone, and it is the only compound other than glutathione to have been tested in a published human clinical trial designed specifically to measure hangover effects.

The study administered intravenous ghrelin to participants in a controlled laboratory setting and compared hangover intensity against placebo. The result was a statistically significant reduction in hangover severity with IV ghrelin, with a p-value of 0.04. The proposed mechanisms involve ghrelin's role in regulating energy homeostasis and blood glucose. Alcohol suppresses gluconeogenesis, the liver process that maintains blood sugar between meals, contributing to the hypoglycemia that compounds hangover fatigue and weakness. Ghrelin also has gastroprotective properties that may help buffer the gastric lining from alcohol-induced damage.

The caveat is significant and the researchers acknowledged it. A separate arm of the same study tested an oral inverse agonist of the ghrelin receptor and found no significant effect on hangover scores. That mixed result suggests the pathway is real but pharmacologically specific: intravenous ghrelin worked; an oral agent acting on the same receptor in the opposite direction did not. This finding is more scientifically interesting than practically useful for most people. Ghrelin is not available as a consumer supplement and is not FDA-approved for hangover relief. Access remains essentially limited to clinical research settings. Its place in this guide reflects the importance of the human trial data, which is genuinely notable in a field where human data is scarce, rather than any expectation that readers will use it in the near term.

5. Semax and Selank: For the Neurological Aftermath

Semax and Selank are both synthetic neuropeptides developed in Russia, Semax derived from a fragment of ACTH and Selank derived from tuftsin, a naturally occurring immune peptide. They are covered together here because they target overlapping aspects of the hangover experience and regularly appear in the same community conversations about cognitive recovery after drinking.

Their proposed relevance is primarily neurological. Alcohol disrupts the balance between GABA, the brain's main inhibitory neurotransmitter, and glutamate, its main excitatory counterpart. As alcohol's suppressive effect wears off, the brain can shift into a glutamate-heavy rebound state, contributing to anxiety, restlessness, and the kind of cognitive irritability that makes a hangover feel worse than just a physical problem. Semax and Selank are both thought to have neuroprotective and calming properties, with animal model evidence for effects on brain-derived neurotrophic factor and glutamate modulation.

The evidence for either compound in hangover recovery is experiential rather than clinical. No human trial has examined them for alcohol-related recovery. Community reports are genuinely mixed: a portion of users, particularly those describing Selank, report meaningful reduction in brain fog and the anxiety component of a rough morning; others report no noticeable effect on hangover symptoms at all. Both are used off-label and accessed through research channels in the US, though they are registered medications in Russia. The honest assessment is that Semax and Selank may help some people with the neurological dimension of a hangover, particularly the anxiety and cognitive components, but they are not a consistent or reliable solution across users, and anyone interested should approach with calibrated expectations rather than confidence.

6. SS-31 (Elamipretide): For Mitochondrial Support in Combination Stacks

SS-31, also known by the investigational name elamipretide, is a synthetic mitochondria-targeted peptide that appears in hangover-recovery protocols primarily for its proposed role in supporting mitochondrial membrane function. It is not among the most widely discussed compounds in this space, but it surfaces consistently enough in community stacks, particularly those paired with glutathione, to warrant an honest entry.

The rationale follows from the same logic as NAD+, though the mechanism is different. Alcohol disrupts mitochondrial function through multiple routes: the metabolic shift caused by ethanol oxidation, the reactive oxygen species generated as a byproduct of that process, and the depletion of cofactors the electron transport chain depends on. SS-31 is thought to act at the level of the mitochondrial inner membrane itself, stabilizing its structure and supporting the efficiency of the electron transport chain directly rather than by replenishing a depleted cofactor. Some community protocols pair it with glutathione and a third compound, Thymosin Alpha-1, framing the combination as targeting both the detoxification pathway and the energy restoration pathway simultaneously. User reports describing this stack are notably enthusiastic, with some accounts characterizing it as capable of fully eliminating hangover symptoms rather than simply reducing them.

No human clinical trial data has been published for SS-31 in hangover recovery or any alcohol-related context as of 2026. SS-31 has been studied in cardiovascular and mitochondrial disease research in humans, so it is not unknown to researchers, but its application to hangover recovery is based entirely on community experimentation and theoretical mechanism extrapolated from that other research. It is a research-only compound in the US and is not available through conventional channels. Treat it as an emerging, unvalidated option with a plausible rationale but no clinical confirmation in this use.

How These Peptides Compare

Frequently Asked Questions

Are these compounds legal to use for hangover recovery?

The legal picture varies by compound. Glutathione is widely available as an oral dietary supplement in the US and is used off-label in IV therapy settings. NAD+ and its precursors are also sold as dietary supplements without restriction. BPC-157 was reclassified in early 2026 to allow compounding by licensed pharmacies under a physician's prescription, making it accessible through telemedicine, though it is also sold through research channels and is prohibited by the World Anti-Doping Agency for competitive athletes. Ghrelin is not available for consumer use and is accessible only through research or clinical settings. Semax, Selank, and SS-31 are research-only compounds in the US. No compound in this guide has been FDA-approved specifically for hangover recovery.

How does the evidence for these compounds compare overall?

Glutathione stands out as the only compound with a published randomized controlled trial demonstrating a hangover-specific effect, specifically a significant reduction in serum acetaldehyde. Ghrelin has a human clinical trial showing reduced hangover intensity via IV administration, though it is not practically accessible for most people. NAD+ has strong mechanistic support and clinical use in alcohol withdrawal, but no dedicated hangover trial. BPC-157 has extensive animal data for gut repair and anti-inflammatory effects but no published human hangover data. Semax, Selank, and SS-31 rest on theoretical mechanisms and user-reported experience. A broader systematic review of hangover interventions across all treatment categories, not only peptides, has concluded that the overall quality of evidence remains low across the board.

Can these compounds be used before drinking, or only afterward?

Community protocols vary on timing. BPC-157 is one of the compounds most often used pre-emptively, with users reporting taking it before and during a drinking occasion rather than only the morning after. Glutathione is used both before bed and the following morning in many user accounts. NAD+ is typically described as a morning-after option focused on energy restoration. The timing question has not been studied rigorously for any of these compounds in a controlled hangover context, so current guidance on timing is based on user-reported experience rather than clinical data.

Do any of these compounds carry safety concerns worth knowing?

Each compound has its own profile. Glutathione in IV or injectable form has a well-established clinical safety record but is not appropriate for people with certain kidney or heart conditions. IV NAD+ can cause transient flushing or discomfort if administered too rapidly. BPC-157 carries a theoretical concern about promoting blood vessel growth in people with active malignancies, and its long-term human safety data is limited. Ghrelin is experimental and not available outside research settings. Semax, Selank, and SS-31 each have limited human safety data for this specific application. None of these compounds should be started without consulting a qualified healthcare professional, particularly for anyone with existing health conditions.

This content is for informational and educational purposes only. It does not constitute medical advice, diagnosis, or treatment recommendations. MyPeptidePal is not a medical provider. Always consult a qualified healthcare professional before starting, modifying, or stopping any health protocol, supplement regimen, or therapeutic intervention.

Sources

The information in this guide is drawn from the MyPeptidePal knowledge base, which brings together published research, clinical data, and documented real-world use of peptides for hangover recovery in one place.